Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weijia Zang

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 4, 2023
[Hematological malignancies driven by aberrant splicing]Weijia Zang, Wataru Saika, Yumi Aoyama, et al.
Cancer Science|June 29, 2022
Dysregulated minor intron splicing in cancerKoutarou Nishimura, Hiromi Yamazaki, Weijia Zang, et al.
Iscience|March 20, 2025
In-depth functional analysis of BRD9 in fetal hematopoiesis reveals context-dependent rolesYifan Zhang, Masaki Nomura, Koutarou Nishimura, et al.
International Journal of Hematology|November 11, 2025
BRD9 depletion-mediated ALOX5 upregulation via chromatin dysregulation induces ferroptosis in SF3B1-mutant hematopoiesisWataru Saika, Hiromi Yamazaki, Shota Tanaka, et al.
Scientific Reports|October 23, 2025
BRD4 and MYB inhibition overcomes venetoclax resistance in EVI1-rearranged acute myeloid leukemiaWeijia Zang, Yui Koike, Koutarou Nishimura, et al.
Leukemia|July 18, 2023
SETBP1 is dispensable for normal and malignant hematopoiesisAtsushi Tanaka, Koutarou Nishimura, Wataru Saika, et al.
Blood|January 8, 2025
Selenoprotein-mediated redox regulation shapes the cell fate of HSCs and mature lineagesYumi Aoyama, Hiromi Yamazaki, Koutarou Nishimura, et al.
Nature Communications|December 15, 2023
BRD9 determines the cell fate of hematopoietic stem cells by regulating chromatin stateMuran Xiao, Shinji Kondo, Masaki Nomura, et al.
Blood|June 16, 2022
Aberrant EVI1 splicing contributes to EVI1-rearranged leukemiaAtsushi Tanaka, Taizo A Nakano, Masaki Nomura, et al.
Blood|December 29, 2025
Comprehensive Molecular and Functional Analysis of NUTM1-Rearranged LeukemiaKoutarou Nishimura, Tomoya Isobe, Tsukasa Shigehiro, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 4, 2023
[Hematological malignancies driven by aberrant splicing]Weijia Zang, Wataru Saika, Yumi Aoyama, et al.
Cancer Science|June 29, 2022
Dysregulated minor intron splicing in cancerKoutarou Nishimura, Hiromi Yamazaki, Weijia Zang, et al.
Iscience|March 20, 2025
In-depth functional analysis of BRD9 in fetal hematopoiesis reveals context-dependent rolesYifan Zhang, Masaki Nomura, Koutarou Nishimura, et al.
International Journal of Hematology|November 11, 2025
BRD9 depletion-mediated ALOX5 upregulation via chromatin dysregulation induces ferroptosis in SF3B1-mutant hematopoiesisWataru Saika, Hiromi Yamazaki, Shota Tanaka, et al.
Scientific Reports|October 23, 2025
BRD4 and MYB inhibition overcomes venetoclax resistance in EVI1-rearranged acute myeloid leukemiaWeijia Zang, Yui Koike, Koutarou Nishimura, et al.
Leukemia|July 18, 2023
SETBP1 is dispensable for normal and malignant hematopoiesisAtsushi Tanaka, Koutarou Nishimura, Wataru Saika, et al.
Blood|January 8, 2025
Selenoprotein-mediated redox regulation shapes the cell fate of HSCs and mature lineagesYumi Aoyama, Hiromi Yamazaki, Koutarou Nishimura, et al.
Nature Communications|December 15, 2023
BRD9 determines the cell fate of hematopoietic stem cells by regulating chromatin stateMuran Xiao, Shinji Kondo, Masaki Nomura, et al.
Blood|June 16, 2022
Aberrant EVI1 splicing contributes to EVI1-rearranged leukemiaAtsushi Tanaka, Taizo A Nakano, Masaki Nomura, et al.
Blood|December 29, 2025
Comprehensive Molecular and Functional Analysis of NUTM1-Rearranged LeukemiaKoutarou Nishimura, Tomoya Isobe, Tsukasa Shigehiro, et al.
Pageof 1